Oxitropium bromide
Clinical data | |
---|---|
Trade names | Oxivent, Tersigan, Tersigat, Ventilat |
AHFS/Drugs.com | International Drug Names |
ATC code | R03BB02 (WHO) |
Identifiers | |
| |
Synonyms | N-Ethylscopolammonium bromide; Ba 253; Ba 253BR-L; Ba 253Br; Hyoscine ethobromide; N-Ethylnorscopolamine methyl bromide; Scopolamine ethobromide |
CAS Number | 30286-75-0 |
ChemSpider | 16735948 |
UNII | SF4NW7NH7C |
ChEMBL | CHEMBL1697846 |
ECHA InfoCard | 100.045.543 |
Chemical and physical data | |
Formula | C19H26BrNO4 |
Molar mass | 412.32 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Oxitropium bromide (trade names Oxivent, Tersigan) is a bronchodilator indicated for asthma and chronic obstructive pulmonary disease.[1]
References
This article is issued from Wikipedia - version of the 8/28/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.